New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

Published Jun 1, 2020

New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

A new drug combination has been approved by the FDA for the treatment of lung cancer. This marks a historic development in research, but an expert says there's still more to be done

NOW
PLAYING
Black Americans Don't Get Screened or Treated for Lung Cancer at the Same Rates as White Americans: Here's Why, and What We Can Do About It
NOW
PLAYING
Thanking God For Waking Up Each Day-- Support For Radio Host Rush Limbaugh During Late-Stage Lung Cancer Battle
NOW
PLAYING
5 COVID-19 Vaccine Questions Answered by Expert Physician
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
New COVID-19 Stimulus Bill Opens Cancer Clinical Trials to Millions Who Were Previously Excluded
NOW
PLAYING
How a Clinical Trial Might Improve Your Outlook

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.